If you're approved, start the program, and then decide it's not for you after medication has been shipped - the refund policy limits your options
Youre not imagining things
2019 Mar 23
Based on Phase 2 trial data (Jastreboff et al., NEJM , 2023), the most commonly reported adverse effects of retatrutide include: Gastrointestinal effects: Nausea, vomiting, diarrhoea, and constipation (most frequent, particularly during dose escalation) Injection site reactions: Redness, bruising, or mild discomfort Decreased appetite: Generally considered a therapeutic effect but can contribute to nutritional deficiency if severe Increased heart rate: Observed with glucagon receptor agonism
If you're currently taking a GLP-1 medication, don't stop it without talking to your healthcare provider
The transient nature of side effects is supported by median duration data showing nausea episodes lasting 8 days, diarrhea 3 days, and vomiting 2 days